Comprehensive Study on Authentication, Isolation, Extraction, Phytochemical Screening and Standardization of Datura Plant

With a focus on the extraction and phytochemical profile of components from the raw plant material, this study provides a thorough analysis of Datura metel. Significant differences in atropine content between plant parts were noted, with important ramifications for medical uses and pharmaceutical development. The results emphasize the need for more research into Datura metel's medicinal potential and production methods by highlighting its rich and varied phytochemical composition. Datura metel's bioactive components, which have demonstrated effectiveness in conditions including bronchitis and asthma, are responsible for its therapeutic qualities. Using a Soxhlet device and variety of solvents, leaf extracts were made. With a maximum extract recovery of 33.28%, the aqueous extract showed the highest yield among all. Tropane alkaloids like scopolamine, atropine, and hyoscyamine, together with withanolides and other related substances, are among the many active ingredients found in datura. The substantial pharmacological potential of withanolides—which have anticancer,cytotoxic, anti-inflammatory, antibacterial, hepatoprotective, sedative, cytostatic, and immunosuppressive qualities—has been notably brought to light by recent studies. These bioactive chemicals were isolated, purified, and characterized from different sections of the Datura metel plant in the current study. Numerous methods have been employed to identify ingredients, according to survey of literature currently in publication, however the data is still dispersed throughout scholarly sources. Both primary metabolites and secondary metabolites have been identified by preliminary qualitative phytochemical screening. These results underline the necessity of more research into Datura metel's therapeutic qualities in order to expand our knowledge and encourage possible uses in pharmaceutical development.